Download the full-sized PDF of Anti-Malarial Strategies Among Vulnerable Populations: exploring bed net underutilization among internally displaced persons and novel adjunctive therapies for cerebral malariaDownload the full-sized PDF



Permanent link (DOI):


Export to: EndNote  |  Zotero  |  Mendeley


This file is in the following communities:

Graduate Studies and Research, Faculty of


This file is in the following collections:

Theses and Dissertations

Anti-Malarial Strategies Among Vulnerable Populations: exploring bed net underutilization among internally displaced persons and novel adjunctive therapies for cerebral malaria Open Access


Other title
Global Health
Public Health
Type of item
Degree grantor
University of Alberta
Author or creator
Brooks, Hannah M
Supervisor and department
Hawkes, Michael T (Pediatrics)
Examining committee member and department
Houston, Stanley (Medicine)
Hanington, Patrick (School of Public Health)
Hawkes, Michael T (Pediatrics)
Yanow, Stephanie (Public Health)
School of Public Health
Global Health
Date accepted
Graduation date
2017-11:Fall 2017
Master of Science
Degree level
Background: Despite declining incidence globally, malaria morbidity and mortality remain elevated among internally displaced persons (IDPs) and children under five, particularly in sub-Saharan Africa. Malaria prevention and treatment efforts in the Democratic Republic of the Congo (DRC) are hindered by armed conflict, which has resulted in the forced displacement of an estimated 1.5 million individuals. Among children under five, cerebral malaria (CM) represents a severe manifestation that may result in death or developmental disability. This thesis has two major focuses: 1) to describe the burden of malaria and reasons for the underutilization of bed nets, a key intervention in malaria control efforts, among IDPs in Eastern DRC; and 2) to test recently licensed pharmaceuticals as putative neuroprotective agents in an in vitro model of CM. Methods: 1) A cross-sectional survey was conducted in Lushebere IDP camp in Eastern DRC to describe the burden of malaria in the population. A second cross-sectional survey was conducted in Birambizo IDP camp in Eastern DRC, supplemented with qualitative descriptions by IDP camp residents, neighbouring villagers, and health workers from the camp, to describe reasons for use and disuse of bed nets among IDPs. 2) An in vitro model of the blood brain barrier (BBB) was created using endothelial and astrocyte cells in a transwell system to test select pharmacological agents in their ability to prevent BBB breakdown, measured as a function of changes in transendothelial electrical resistance (TEER). Three challenges were independently used to compromise endothelial monolayer integrity: tumour necrosis factor (TNF), vascular endothelial growth factor (VEGF) and Plasmodium falciparum infected red blood cells (Pf-IRBCs). Pharmacological agents are recently licensed and were tested at physiologically plausible concentrations. Results: The proportion of IDP camp residents who tested positively for malaria via rapid diagnostic test was high, particularly among children under five (61% of febrile children under 5 in Lushebere, and 58% of children under 5 in Birambizo). Despite free bed net distribution campaigns throughout both camps, bed net ownership and use was low (36% in Lushebere and 29% in Birambizo). Focus group discussions revealed several pragmatic barriers to bed net use within the camp setting and competing needs for ii nutrition which often drove individuals to sell or exchange their nets in order to feed their families. In our in vitro studies of CM, three pharmacologic agents were successful in rescuing BBB break down induced by either TNF, VEGF, or Pf-IRBCs: fingolimod, sunitinib, and pazopanib. If successful in future in vivo studies and human clinical trials, these recently licensed agents may be repurposed for use as adjunctive therapies in CM. Conclusions: These studies highlight the burden of malaria among two key vulnerable populations: IDPs and children under five. Our findings call attention to the need for new and improved malaria control and treatment efforts within these populations. Current malaria vector control and cerebral malaria adjunctive therapies are incompletely effective for IDPs in regions of sub-Saharan Africa and children under five, respectively. Global efforts to further reduce malaria associated morbidity and mortality should not forget vulnerable and often hard-to-reach populations, and efforts should be tailored to meet the individual needs of these large populations if progress is to be made.
This thesis is made available by the University of Alberta Libraries with permission of the copyright owner solely for the purpose of private, scholarly or scientific research. This thesis, or any portion thereof, may not otherwise be copied or reproduced without the written consent of the copyright owner, except to the extent permitted by Canadian copyright law.
Citation for previous publication
Brooks, H.M., et al., Malaria in an Internally Displaced Persons Camp in the Democratic Republic of the Congo. Clinical Infectious Diseases, 2017Brooks, H. and M. Hawkes, Repurposing Pharmaceuticals as Neuroprotective Agents for Cerebral Malaria. Current clinical pharmacology, 2017.

File Details

Date Uploaded
Date Modified
Audit Status
Audits have not yet been run on this file.
File format: pdf (Portable Document Format)
Mime type: application/pdf
File size: 2067136
Last modified: 2017:11:08 16:29:04-07:00
Filename: Brooks_Hannah_M_201709_MSc.pdf
Original checksum: 5c026095ab7f0db088b20239ec30f5c5
Well formed: true
Valid: true
File title: Hannah Myfanwy Brooks
File author: Hannah Brooks
Page count: 109
Activity of users you follow
User Activity Date